Search
for
Sort by
Research 901–930 of 1000+
- 14. Wound Healing; Cutaneous Therapy; Hair
- Diagnosing Vascular Causes of Renal Failure
- The PDGF/PDGFR pathway as a drug target
- Replicative stress, stem cells and aging
- Mechanical forces in skin disorders
- Interventions for morphea
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Immunomodulators in the treatment of cutaneous lymphoma
- Localized Primary Cutaneous Nodular Amyloidosis in a Patient With Paraproteinemia
- Uso actual de la vitamina D en dermatología
- Gene Variant in Amish a Clue to Better Aging
- Assessment of the impact of VDR polymorphisms on selected hormonal, metabolic and mineral balance markers in young women with hyperandrogenism
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- HEAVY METALS IN DRINKING WATER AND THEIR ENVIRONMENTAL IMPACT ON HUMAN HEALTH
- Bioregenerative Applications of the Human Mesenchymal Stem Cell- Derived Secretome: Part-II
- Pharmacology of anabolic steroids
- Stem cell niches in mammals
- Albendazole treatment of echinococcosis in humans: Effects on microsomal metabolism and drug tolerance
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- Analysis of the FGF gene family provides insights into aquatic adaptation in cetaceans
- Signal transducer and activator of transcription 5B deficiency due to a novel missense mutation in the coiled-coil domain
- Polymorphisms in androgen and estrogen receptor genes: effects on male aging
- TNC+ fibroblasts involve in skin inflammation via neuro-immune and interacting with T cells
- Decades of progressive red and yellow nodules
- The in vitro plasticity of hair follicle dermal and mesenchymal stem cells
- Anti-ageing effect of a lactococcal strain: analysis using senescence-accelerated mice
- Prospect of Stem Cell Conditioned Medium in Regenerative Medicine
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Cutaneous lupus erythematosus